+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Remdesivir Market, By Dosage Form (Lyophilized Solution, Frozen Solution), By Route of Administration (Intravenous, Inhalation), By Patient Age, By Application, By Distribution Channel, By Region, Competition Forecast & Opportunities, 2026

  • PDF Icon

    Report

  • 114 Pages
  • August 2021
  • Region: Global
  • TechSci Research
  • ID: 5401739
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Remdesivir Market is expected to reach USD9913.38 million by 2026. Remdesivir, a drug originally developed by Gilead Sciences, Inc. for the treatment of Ebola, is an antiviral medication belonging to the drug class of protease inhibitors. Remdesivir is a nucleotide analog particularly of adenosine, which shuts down the viral replication process by inhibiting the activity of an important viral enzyme RNA-dependent RNA polymerase. The drug basically causes mutation in viral genome and blocks polymerase enzymes function, which brings about premature termination of viral replication.





The Global Remdesivir Market is driven by the increasing prevalence of COVID-19 pandemic across different parts of the globe. Remdesivir has been found to be effective in treating novel coronavirus disease patients across different parts of the globe. The Chinese have also been using the drug on compassionate use basis. Additionally, the drug was also used on the very first COVID-19 patient in the US, a young man in Snohomish country in Washington. He was given the drug when his condition worsened, and signs of improvement were observed on the very next day in his condition after the drug administration. A Californian patient, who the doctors thought, will not survive, also recovered after getting remdesivir. Promising results were also observed in Japan on 14 patients. After such cases and evidences, the US Food and Drug Administration granted approval to Remdesivir in Oct 2020 and the world is hoping that it will emerge out as a successful coronavirus treatment in coming years as well.



The Global Remdesivir Market is segmented based on dosage form, route of administration, patient age, distribution channel, application, company, and region. Based on dosage form, the market can be categorized into frozen solution, and lyophilized solution. The lyophilized segment is expected to hold significant market share on account of their longer shelf life. Additionally, they are cost effective, safe and an effective way to deliver medication.



Regionally, Asia Pacific is expected to witness significant growth during the forecast period in the overall remdesivir market owing to increasing number of COVID-19 patients and huge number of hospitalization cases along with increasing demand for remdesivir for the treatment of COVID-19.



Major players operating in the Global Remdesivir Market include Gilead Sciences, Inc., Cipla Ltd., Hetero Labs Ltd., Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.), Dr Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Jubilant Pharmova Ltd., Eva Pharma, Ferozsons Laboratories and others.



Years considered for this report:

  • Base Year: 2020
  • Estimated Year: 2021E
  • Forecast Period: 2022F-2026F

Objective of the Study:

  • To analyze and estimate the market size of the Global Remdesivir Market in 2020.
  • To estimate and forecast the market size of the Global Remdesivir Market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast the Global Remdesivir Market based on dosage form, route of administration, patient age, application, distribution channel, company, and regional distribution.
  • To identify dominant region or segment in the Global Remdesivir Market.
  • To identify drivers and challenges for the Global Remdesivir Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Remdesivir Market.
  • To conduct pricing analysis for the Global Remdesivir Market.
  • To identify and analyze the profile of leading players operating in the Global Remdesivir Market.
  • To identify key sustainable strategies adopted by market players in the Global Remdesivir Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers which could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers, distribution channels and presence of all major players across the globe.



The publisher calculated the market size of the Global Remdesivir Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.



Key Target Audience:

  • Remdesivir manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to remdesivir
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.



Report Scope:


In this report, the Global Remdesivir Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:



Global Remdesivir Market, By Dosage Form:


  • Lyophilized Solution
  • Frozen Solution

Global Remdesivir Market, By Route of Administration:


  • Intravenous
  • Inhalation

Global Remdesivir Market, By Patient Age:


  • Geriatric
  • Adult
  • Pediatric

Global Remdesivir Market, By Application:


  • SARS-CoV-2 (COVID-19)
  • MERS-CoV
  • Ebola
  • SARS-CoV

Global Remdesivir Market, By Distribution Channel:


  • Hospitals
  • Clinics
  • Drug Stores and Pharmacies

Global Remdesivir Market, By Region:


  • North America
  • United States
  • Mexico
  • Canada
  • Asia-Pacific
  • India
  • Japan
  • China
  • South Korea
  • Australia
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • Iran
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Remdesivir Market.



Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


Please note: With the Enterprise license, the PDF product is printable and editable and comes with a market data excel sheet.

Frequently Asked Questions about the Global Remdesivir Market

What is the estimated value of the Global Remdesivir Market?

The Global Remdesivir Market was estimated to be valued at $7441.61 Million in 2020.

What is the growth rate of the Global Remdesivir Market?

The growth rate of the Global Remdesivir Market is 4.9%, with an estimated value of $9913.38 Million by 2026.

What is the forecasted size of the Global Remdesivir Market?

The Global Remdesivir Market is estimated to be worth $9913.38 Million by 2026.

Who are the key companies in the Global Remdesivir Market?

Key companies in the Global Remdesivir Market include Gilead Sciences, Inc., Cipla Ltd., Hetero Labs Ltd., Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.), Dr Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Jubilant Pharmova Ltd. and Ferozsons Laboratories.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Remdesivir Market4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness (Aided/Unaided)
5.2. Product Awareness
5.3. Customer Satisfaction Analysis
5.4. Unmet Needs/Challenges
6. Global Remdesivir Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Dosage Form (Lyophilized Solution, Frozen Solution)
6.2.2. By Route of Administration (Intravenous, Inhalation)
6.2.3. By Patient Age (Geriatric, Adult, Pediatric)
6.2.4. By Application (SARS-CoV-2 (COVID-19), MERS-CoV, Ebola, SARS-CoV)
6.2.5. By Distribution Channel (Hospitals, Clinics, Drug Stores and Pharmacies)
6.2.6. By Company (2020)
6.2.7. By Region
6.3. Product Market Map
7. North America Remdesivir Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Dosage Form
7.2.2. By Route of Administration
7.2.3. By Patient Age
7.2.4. By Application
7.2.5. By Distribution Channel
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Remdesivir Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Dosage Form
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Patient Age
7.3.1.2.4. By Application
7.3.1.2.5. By Distribution Channel
7.3.2. Mexico Remdesivir Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Dosage Form
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Patient Age
7.3.2.2.4. By Application
7.3.2.2.5. By Distribution Channel
7.3.3. Canada Remdesivir Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Dosage Form
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Patient Age
7.3.3.2.4. By Application
7.3.3.2.5. By Distribution Channel
8. Asia-Pacific Remdesivir Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Dosage Form
8.2.2. By Route of Administration
8.2.3. By Patient Age
8.2.4. By Application
8.2.5. By Distribution Channel
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. India Remdesivir Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Dosage Form
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Patient Age
8.3.1.2.4. By Application
8.3.1.2.5. By Distribution Channel
8.3.2. Japan Remdesivir Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Dosage Form
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Patient Age
8.3.2.2.4. By Application
8.3.2.2.5. By Distribution Channel
8.3.3. China Remdesivir Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Dosage Form
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Patient Age
8.3.3.2.4. By Application
8.3.3.2.5. By Distribution Channel
8.3.4. South Korea Remdesivir Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Dosage Form
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By Patient Age
8.3.4.2.4. By Application
8.3.4.2.5. By Distribution Channel
8.3.5. Australia Remdesivir Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Dosage Form
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By Patient Age
8.3.5.2.4. By Application
8.3.5.2.5. By Distribution Channel
9. Europe Remdesivir Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Dosage Form
9.2.2. By Route of Administration
9.2.3. By Patient Age
9.2.4. By Application
9.2.5. By Distribution Channel
9.2.6. By Country
9.3. Europe: Country Analysis
9.3.1. France Remdesivir Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Dosage Form
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Patient Age
9.3.1.2.4. By Application
9.3.1.2.5. By Distribution Channel
9.3.2. United Kingdom Remdesivir Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Dosage Form
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Patient Age
9.3.2.2.4. By Application
9.3.2.2.5. By Distribution Channel
9.3.3. Italy Remdesivir Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Dosage Form
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Patient Age
9.3.3.2.4. By Application
9.3.3.2.5. By Distribution Channel
9.3.4. Germany Remdesivir Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Dosage Form
9.3.4.2.2. By Route of Administration
9.3.4.2.3. By Patient Age
9.3.4.2.4. By Application
9.3.4.2.5. By Distribution Channel
9.3.5. Spain Remdesivir Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Dosage Form
9.3.5.2.2. By Route of Administration
9.3.5.2.3. By Patient Age
9.3.5.2.4. By Application
9.3.5.2.5. By Distribution Channel
10. South America Remdesivir Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Dosage Form
10.2.2. By Route of Administration
10.2.3. By Patient Age
10.2.4. By Application
10.2.5. By Distribution Channel
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Remdesivir Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Dosage Form
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By Patient Age
10.3.1.2.4. By Application
10.3.1.2.5. By Distribution Channel
10.3.2. Argentina Remdesivir Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Dosage Form
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By Patient Age
10.3.2.2.4. By Application
10.3.2.2.5. By Distribution Channel
10.3.3. Colombia Remdesivir Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Dosage Form
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By Patient Age
10.3.3.2.4. By Application
10.3.3.2.5. By Distribution Channel
11. Middle East and Africa Remdesivir Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Dosage Form
11.2.2. By Route of Administration
11.2.3. By Patient Age
11.2.4. By Application
11.2.5. By Distribution Channel
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. Iran Remdesivir Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Dosage Form
11.3.1.2.2. By Route of Administration
11.3.1.2.3. By Patient Age
11.3.1.2.4. By Application
11.3.1.2.5. By Distribution Channel
11.3.2. South Africa Remdesivir Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Dosage Form
11.3.2.2.2. By Route of Administration
11.3.2.2.3. By Patient Age
11.3.2.2.4. By Application
11.3.2.2.5. By Distribution Channel
11.3.3. UAE Remdesivir Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Dosage Form
11.3.3.2.2. By Route of Administration
11.3.3.2.3. By Patient Age
11.3.3.2.4. By Application
11.3.3.2.5. By Distribution Channel
11.3.4. Saudi Arabia Remdesivir Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Dosage Form
11.3.4.2.2. By Route of Administration
11.3.4.2.3. By Patient Age
11.3.4.2.4. By Application
11.3.4.2.5. By Distribution Channel
11.3.5. Kuwait Remdesivir Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Dosage Form
11.3.5.2.2. By Route of Administration
11.3.5.2.3. By Patient Age
11.3.5.2.4. By Application
11.3.5.2.5. By Distribution Channel
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments14. Pricing Analysis15. Patent Analysis
16. Competitive Landscape
16.1. Gilead Sciences, Inc.
16.2. Cipla Ltd.
16.3. Hetero Labs Ltd.
16.4. Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.)
16.5. Dr Reddy's Laboratories Ltd.
16.6. Sun Pharmaceutical Industries Ltd.
16.7. Cadila Healthcare Ltd.
16.8. Jubilant Pharmova Ltd.
16.9. Eva Pharma Ltd.
16.10. Ferozsons Laboratories
17. Strategic Recommendations18. About the Publisher & Disclaimer
List of Figures
Figure 1: Global Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 2: Global Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 3: Global Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 4: Global Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 5: Global Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 6: Global Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 7: Global Remdesivir Market Share, By Company, By Value, 2020
Figure 8: Global Remdesivir Market Share, By Region, By Value, 2020-2026F
Figure 9: Global Remdesivir Product Market Map, By Value, 2020-2026F
Figure 10: North America Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 11: North America Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 12: North America Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 13: North America Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 14: North America Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 15: North America Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 16: North America Remdesivir Market Share, By Country, By Value, 2020-2026F
Figure 17: United States Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 18: United States Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 19: United States Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 20: United States Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 21: United States Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 22: United States Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 23: Mexico Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 24: Mexico Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 25: Mexico Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 26: Mexico Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 27: Mexico Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 28: Mexico Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 29: Canada Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 30: Canada Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 31: Canada Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 32: Canada Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 33: Canada Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 34: Canada Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 35: Asia-Pacific Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 36: Asia-Pacific Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 37: Asia-Pacific Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 38: Asia-Pacific Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 39: Asia-Pacific Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 40: Asia-Pacific Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 41: Asia-Pacific Remdesivir Market Share, By Country, By Value, 2020-2026F
Figure 42: India Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 43: India Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 44: India Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 45: India Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 46: India Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 47: India Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 48: Japan Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 49: Japan Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 50: Japan Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 51: Japan Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 52: Japan Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 53: Japan Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 54: China Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 55: China Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 56: China Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 57: China Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 58: China Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 59: China Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 60: South Korea Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 61: South Korea Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 62: South Korea Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 63: South Korea Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 64: South Korea Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 65: South Korea Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 66: Australia Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 67: Australia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 68: Australia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 69: Australia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 70: Australia Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 71: Australia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 72: Europe Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 73: Europe Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 74: Europe Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 75: Europe Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 76: Europe Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 77: Europe Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 78: Europe Remdesivir Market Share, By Country, By Value, 2020-2026F
Figure 79: France Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 80: France Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 81: France Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 82: France Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 83: France Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 84: France Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 85: United Kingdom Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 86: United Kingdom Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 87: United Kingdom Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 88: United Kingdom Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 89: United Kingdom Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 90: United Kingdom Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 91: Italy Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 92: Italy Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 93: Italy Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 94: Italy Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 95: Italy Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 96: Italy Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 97: Germany Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 98: Germany Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 99: Germany Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 100: Germany Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 101: Germany Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 102: Germany Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 103: Spain Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 104: Spain Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 105: Spain Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 106: Spain Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 107: Spain Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 108: Spain Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 109: South America Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 110: South America Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 111: South America Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 112: South America Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 113: South America Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 114: South America Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 115: South America Remdesivir Market Share, By Country, By Value, 2020-2026F
Figure 116: Brazil Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 117: Brazil Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 118: Brazil Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 119: Brazil Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 120: Brazil Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 121: Brazil Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 122: Argentina Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 123: Argentina Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 124: Argentina Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 125: Argentina Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 126: Argentina Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 127: Argentina Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 128: Colombia Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 129: Colombia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 130: Colombia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 131: Colombia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 132: Colombia Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 133: Colombia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 134: Middle East and Africa Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 135: Middle East and Africa Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 136: Middle East and Africa Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 137: Middle East and Africa Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 138: Middle East and Africa Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 139: Middle East and Africa Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 140: Middle East and Africa Remdesivir Market Share, By Country, By Value, 2020-2026F
Figure 141: Iran Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 142: Iran Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 143: Iran Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 144: Iran Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 145: Iran Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 146: Iran Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 147: South Africa Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 148: South Africa Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 149: South Africa Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 150: South Africa Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 151: South Africa Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 152: South Africa Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 153: UAE Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 154: UAE Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 155: UAE Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 156: UAE Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 157: UAE Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 158: UAE Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 159: Saudi Arabia Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 160: Saudi Arabia Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 161: Saudi Arabia Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 162: Saudi Arabia Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 163: Saudi Arabia Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 164: Saudi Arabia Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F
Figure 165: Kuwait Remdesivir Market Size, By Value (USD Million), 2020-2026F
Figure 166: Kuwait Remdesivir Market Share, By Dosage Form, By Value, 2020-2026F
Figure 167: Kuwait Remdesivir Market Share, By Route of Administration, By Value, 2020-2026F
Figure 168: Kuwait Remdesivir Market Share, By Patient Age, By Value, 2020-2026F
Figure 169: Kuwait Remdesivir Market Share, By Application, By Value, 2020-2026F
Figure 170: Kuwait Remdesivir Market Share, By Distribution Channel, By Value, 2020-2026F

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Gilead Sciences, Inc.
  • Cipla Ltd.
  • Hetero Labs Ltd.
  • Meda Pharma SA (VIATRIS Pharmaceuticals Ltd.)
  • Dr Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Cadila Healthcare Ltd.
  • Jubilant Pharmova Ltd.
  • Eva Pharma Ltd.
  • Ferozsons Laboratories